Department of Orthopedics, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Shanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Disease, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Mol Genet Genomic Med. 2022 Oct;10(10):e2043. doi: 10.1002/mgg3.2043. Epub 2022 Aug 25.
Melorheostosis (MEL) is an exceptionally rare sclerosing bone dysplasia with asymmetrically exuberant bone formation and soft tissue lesions in a segmental distribution. We aimed to summarize the clinical characteristics of Chinese MEL patients and identify their pathogenic cause.
In total, 10 Chinese MEL patients were recruited, and clinical manifestations and radiological characteristics were recorded. Sanger sequencing of the LEMD3 gene was performed on peripheral blood samples of all patients, while the exome sequencing of matched peripheral blood, melorheostotic bone, and skin lesion samples was conducted on one patient who provided affected bone and skin tissues. Micro-computed tomography (micro-CT) was also used to scan the melorheostotic bone tissue.
We found the average age of the 10 MEL patients was 29.5 years (range 11-40 years), and the major symptoms were bone pain, restricted movement, and bone deformity. The lesions sites were mainly located in femur (8/10), tibia (8/10), fibula (6/10), and foot (7/10), the next was pelvis (4/10), and the last were patella (1/10), hand (1/10) and spine (1/10). Radiological examinations showed a mixture of hyperostosis consisting of classic "dripping candle wax," "osteoma-like," or "myositis ossificans-like" patterns in most patients. No germline pathogenic variants in the LEMD3 gene were found in all patients, but a disease-causing somatic variant of MAP2K1 (c.167A > C, p.Gln56Pro) was detected in melorheostotic bone from one patient. Moreover, the micro-CT analysis showed increased porosity in the melorheostotic bone with somatic MAP2K1 variant.
This is a summary of the clinical characteristics of Chinese MEL patients and we first identify the somatic MAP2K1 variant in Chinese patients. Our findings validate the molecular genetic mechanism of MEL and broaden its phenotype spectrum in the Chinese population.
Melorheostosis(MEL)是一种罕见的硬化性骨发育不良,具有节段性分布的不对称性骨形成和软组织病变。我们旨在总结中国 MEL 患者的临床特征,并确定其致病原因。
共招募了 10 名中国 MEL 患者,记录了临床表现和影像学特征。对所有患者的外周血样本进行了 LEMD3 基因的 Sanger 测序,而对一名提供受累骨和皮肤组织的患者的外周血、MEL 骨质和皮肤病变样本进行了外显子组测序。还使用微计算机断层扫描(micro-CT)扫描了 MEL 骨质组织。
我们发现 10 名 MEL 患者的平均年龄为 29.5 岁(范围 11-40 岁),主要症状为骨痛、运动受限和骨畸形。病变部位主要位于股骨(8/10)、胫骨(8/10)、腓骨(6/10)和足部(7/10),其次是骨盆(4/10),最后是髌骨(1/10)、手(1/10)和脊柱(1/10)。影像学检查显示,大多数患者的骨质增生混合有经典的“滴蜡样”、“骨瘤样”或“骨化性肌炎样”模式。在所有患者中均未发现 LEMD3 基因的种系致病性变异,但在一名患者的 MEL 骨质中检测到 MAP2K1 (c.167A>C,p.Gln56Pro)致病体细胞变异。此外,微 CT 分析显示具有体细胞 MAP2K1 变异的 MEL 骨质的孔隙度增加。
这是对中国 MEL 患者临床特征的总结,我们首次在中国患者中发现了体细胞 MAP2K1 变异。我们的发现验证了 MEL 的分子遗传机制,并拓宽了其在中国人群中的表型谱。